StockData
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Axogen, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$35.24+0.62 (+1.79%)

Close on Oct 19, 2026

Market cap
$1.88B
P/E (TTM)
–
Dividend yield
–

Axogen, Inc. balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
74.6%
Operating margin
-5.1%
Net margin
-13.4%
Return on equity, FY2025
-13.5%

Financial strength

Current ratio
6.60
Debt to equity
0.00
Debt to assets
0.0%
Cash to current liabilities
311.4%

Valuation

P/E ratio
–
Price to sales
7.48
Price to book
7.34
Dividend yield
–